Korea And U.S. Expected To Sign Korea-U.S. FTA Before G20 Summit In Seoul; No Surprises For Pharma
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Ahead of U.S. President Barack Obama's visit to Seoul Nov. 11-12 for the G20 Summit, South Korea and the U.S. are renegotiating the Korea-U.S. free trade agreement, which was agreed upon in 2007 but yet to be ratified by each other's government
You may also be interested in...
Delay In Approval Of U.S.-Korea Free Trade Agreement Could Give EU Companies Advantage Over U.S. Counterparts
SEOUL - U.S. President Barack Obama and South Korean President Lee Myung-bak failed to finalize a revised free trade agreement at the G20 Seoul Summit, raising the likelihood that the U.S. will be unable to ratify the agreement before a similar EU-Korea pact
Delay In Approval Of U.S.-Korea Free Trade Agreement Could Give EU Companies Advantage Over U.S. Counterparts
SEOUL - U.S. President Barack Obama and South Korean President Lee Myung-bak failed to finalize a revised free trade agreement at the G20 Seoul Summit, raising the likelihood that the U.S. will be unable to ratify the agreement before a similar EU-Korea pact
U.S. And South Korean Presidents Say More Negotiation Needed To Ratify Free Trade Agreement But Pharma Provisions Seen Intact
SEOUL - Although South Korean President Lee Myung-bak and U.S. President Barack Obama last week hinted at the possibility of more talks or a partial revision of their bilateral Free Trade Agreement in the U.S. Congress, pharma provisions outlined in the FTA aren't likely to be a bone of contention